Alnylam Pharmaceuticals · 3 days ago
Associate Director, Field Operations
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, committed to transforming lives through innovative science. The Associate Director, Field Operations will partner with U.S. field-based teams to ensure effective execution of commercial strategies by defining success metrics and leading cross-functional collaborations.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Engage effectively in strategic discussions with leadership of field-based teams, including TTR Sales, Rare Sales, Market Access, and Strategic Accounts
Define what success looks like for field teams including the metrics used to measure results
Identify key activities that are expected to drive the desired results and define Key Performance Indicators
Work with cross-functional partners to establish dashboards and generate insights from the data to help shape strategy
Lead the development of presentation materials to support monthly and quarterly leadership performance reviews
Drive consistency in field execution through clear processes, playbooks, and standard operating procedures
Partner with Compliance and Legal to ensure field team activities adhere to company policies and industry regulations
Serve as the liaison between field teams and headquarters functions (Market Access Strategy, Patient Services, Marketing, Compliance)
Support change management efforts when deploying new processes, systems, or field strategies
Lead the field-facing efforts to maintain and improve HCP-to-account affiliation mapping
Help identify incorrect affiliations and establish processes for implementing changes
Qualification
Required
Bachelor's degree required; advanced degree preferred
10+ years of experience in a related role, preferably within the pharmaceutical or biotechnology industry
Proven experience partnering with field teams and presenting to senior leadership
Strong experience working with CRM platforms and commercial data environments
Hands-on experience with data visualization tools (e.g., Tableau, Power BI, etc)
Demonstrated expertise in field force effectiveness, alignments, HCP segmentation, reporting, size and structure, and strategic analysis
Experience across multiple commercial functions, including operations and strategy
Strong analytical skills with experience leveraging pharmaceutical data sources to generate and iterate on insights
Advanced proficiency in Excel and PowerPoint
Highly organized, agile learner with the ability to think in real time and communicate effectively
High sense of urgency balanced with attention to quality, rigor, and process
Strong interpersonal and communication skills with the ability to influence at all levels of the organization
Demonstrated project management skills with the ability to lead multiple initiatives and priorities concurrently
Experience working directly with field teams; prior field experience strongly preferred
Ability to travel for key internal and external meetings as needed (approximately 10% overnight travel)
Benefits
Comprehensive benefits including medical, dental, and vision coverage
Life and disability insurance
A lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Recent News
Clinical Trials Arena
2026-01-16
Longevity.Technology
2026-01-14
2026-01-13
Company data provided by crunchbase